Nancy Newman

2.3k total citations
50 papers, 1.8k citations indexed

About

Nancy Newman is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, Nancy Newman has authored 50 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 18 papers in Oncology and 10 papers in Epidemiology. Recurrent topics in Nancy Newman's work include Lung Cancer Treatments and Mutations (11 papers), Lung Cancer Research Studies (8 papers) and Lung Cancer Diagnosis and Treatment (6 papers). Nancy Newman is often cited by papers focused on Lung Cancer Treatments and Mutations (11 papers), Lung Cancer Research Studies (8 papers) and Lung Cancer Diagnosis and Treatment (6 papers). Nancy Newman collaborates with scholars based in United States, Germany and Vietnam. Nancy Newman's co-authors include Stephen L. Graziano, Leslie J. Kohman, Gary P. Gamble, Lori Mosca, Leslie G. Bluman, Ajeet Gajra, Arthur H. Tatum, Albert Oler, Bernard J. Poiesz and John J. Gullo and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Nancy Newman

47 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nancy Newman United States 19 860 597 368 306 205 50 1.8k
Kengo Nagashima Japan 25 617 0.7× 715 1.2× 523 1.4× 259 0.8× 237 1.2× 191 2.0k
Thomas E. Delea United States 26 529 0.6× 763 1.3× 304 0.8× 298 1.0× 131 0.6× 136 2.4k
Roderick Skinner United Kingdom 33 432 0.5× 557 0.9× 219 0.6× 552 1.8× 215 1.0× 109 3.2k
Michael Goodyear Canada 21 546 0.6× 784 1.3× 784 2.1× 216 0.7× 158 0.8× 36 2.4k
Heather Anderson United Kingdom 29 1.1k 1.3× 1.3k 2.2× 439 1.2× 489 1.6× 422 2.1× 99 2.9k
Maureen P. Neary United States 25 538 0.6× 717 1.2× 362 1.0× 263 0.9× 535 2.6× 111 2.4k
Elizabeth Harvey Canada 24 634 0.7× 322 0.5× 310 0.8× 387 1.3× 178 0.9× 97 2.3k
Florian Scotté France 27 459 0.5× 1.1k 1.8× 395 1.1× 298 1.0× 138 0.7× 131 2.0k
Domenico Ferrigno Italy 28 1.2k 1.4× 1.3k 2.2× 181 0.5× 434 1.4× 354 1.7× 85 2.4k
Laura Giordano Italy 31 873 1.0× 982 1.6× 305 0.8× 387 1.3× 318 1.6× 165 3.3k

Countries citing papers authored by Nancy Newman

Since Specialization
Citations

This map shows the geographic impact of Nancy Newman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy Newman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy Newman more than expected).

Fields of papers citing papers by Nancy Newman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy Newman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy Newman. The network helps show where Nancy Newman may publish in the future.

Co-authorship network of co-authors of Nancy Newman

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy Newman. A scholar is included among the top collaborators of Nancy Newman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy Newman. Nancy Newman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tchelebi, Leila T., Ethan B. Ludmir, Freddy E. Escorcia, et al.. (2025). Meta‐analysis of randomized controlled trials of external‐beam radiation versus transarterial chemoembolization for hepatocellular carcinoma. Cancer. 131(3). e35720–e35720.
2.
Newman, Nancy, Mark Yarchoan, Atoosa Rabiee, et al.. (2025). Advances in radiation therapy for HCC: Integration with liver-directed treatments. Hepatology Communications. 9(4). 1 indexed citations
3.
Thakral, Charu, et al.. (2012). Activation of mammalian target of rapamycin in diffuse large B-cell lymphoma: A clinicopathological study. Leukemia Research. 36(11). 1403–1409. 13 indexed citations
4.
5.
Newman, Nancy, et al.. (2008). Use of Telemedicine to Improve Glycemic Management in Correctional Institutions. Journal of Correctional Health Care. 14(3). 197–201. 10 indexed citations
6.
Newman, Nancy, et al.. (2008). Sweat Chloride Testing in Infants Identified as Heterozygote Carriers by Newborn Screening. The Journal of Pediatrics. 153(6). 857–859. 7 indexed citations
7.
Newman, Nancy, et al.. (2005). Heterocyclic amines and genotype of N-acetyltransferases as risk factors for prostate cancer. Prostate Cancer and Prostatic Diseases. 8(1). 69–74. 39 indexed citations
8.
Phillips, Elizabeth M., et al.. (2005). Low‐Molecular‐Weight Heparin May Alter Point‐of‐Care Assay for International Normalized Ratio. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 25(10). 1341–1347. 14 indexed citations
9.
10.
Gajra, Ajeet, et al.. (2003). Impact of tumor size on survival in stage IA non-small cell lung cancer: a case for subdividing stage IA disease. Lung Cancer. 42(1). 51–57. 109 indexed citations
11.
Gajra, Ajeet, Arthur H. Tatum, Nancy Newman, et al.. (2002). The predictive value of neuroendocrine markers and p53 for response to chemotherapy and survival in patients with advanced non-small cell lung cancer. Lung Cancer. 36(2). 159–165. 36 indexed citations
12.
Mehdi, Syed A., Arthur H. Tatum, Nancy Newman, et al.. (1999). Prognostic Markers in Resected Non–Small-Cell Lung Cancer: An Patients with 5 Year Follow-Up. Clinical Lung Cancer. 1(1). 59–67. 26 indexed citations
13.
Bluman, Leslie G., et al.. (1998). Preoperative Smoking Habits and Postoperative Pulmonary Complications. CHEST Journal. 113(4). 883–889. 306 indexed citations
14.
Mehdi, Syed A., et al.. (1998). Prognostic Significance of Lewis y Antigen in Resected Stage I and II Non-small Cell Lung Cancer. CHEST Journal. 114(5). 1309–1315. 13 indexed citations
15.
Mehdi, Syed A., Joan Etzell, Nancy Newman, et al.. (1998). Prognostic significance of Ki-67 immunostaining and symptoms in resected stage I and II non-small cell lung cancer1Supported by Veterans Affairs Research Service.1. Lung Cancer. 20(2). 99–108. 39 indexed citations
16.
Lehmann, David F., et al.. (1997). Anticonvulsant usage is associated with an increased risk of procarbazine hypersensitivity reactions in patients with brain tumors. Clinical Pharmacology & Therapeutics. 62(2). 225–229. 28 indexed citations
17.
Eley, J. William, et al.. (1991). A survey of alcohol use in an inner-city ambulatory care setting. Journal of General Internal Medicine. 6(4). 295–298. 14 indexed citations
18.
Newman, Nancy, Sandra J. Ginsberg, Arthur C. Louie, et al.. (1989). Phase II Study of Iproplatin (CHIP) in Previously Treated Small-Cell Lung Cancer. American Journal of Clinical Oncology. 12(4). 355–357. 6 indexed citations
19.
Graziano, Stephen L., Nancy Newman, Arthur H. Tatum, et al.. (1989). The use of neuroendocrine immunoperoxidase markers to predict chemotherapy response in patients with non-small-cell lung cancer.. Journal of Clinical Oncology. 7(10). 1398–1406. 157 indexed citations
20.
Newman, Nancy, et al.. (1988). Phase II Trial of Iproplatin (CHIP) in Previously Untreated Patients with Colorectal Cancer. American Journal of Clinical Oncology. 11(6). 650–651. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kengo Nagashima Breakdown of academic impact, for papers by Thomas E. Delea Breakdown of academic impact, for papers by Roderick Skinner Breakdown of academic impact, for papers by Michael Goodyear Breakdown of academic impact, for papers by Heather Anderson Breakdown of academic impact, for papers by Maureen P. Neary Breakdown of academic impact, for papers by Elizabeth Harvey Breakdown of academic impact, for papers by Florian Scotté Breakdown of academic impact, for papers by Domenico Ferrigno Breakdown of academic impact, for papers by Laura Giordano
Rankless by CCL
2026